Prelude Capital Management’s Acumen Pharmaceuticals ABOS Stock Holding History

Prelude Capital Management’s Portfolio ABOS Stock Details ABOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell
2024 Q4	$83.3K	Sell
2024 Q3	$130K	Buy
2024 Q2	$112K	Buy
2024 Q1	$150K	Buy
2023 Q4	$112K	Buy
2023 Q3	–	Sell
2023 Q2	$150K	Buy
2022 Q3	–	Sell
2022 Q2	$87K	Buy
2022 Q1	$61K	Buy